Generex unveils updated corporate website
WORCESTER, Mass. — Generex Biotechnology has revamped its corporate website to underscore the company’s focus on the development and approval of its diabetes and immunotherapeutic vaccine products pipeline.
The company said that the site will provide improved descriptions of products, technologies, scientific research in progress, trial results and new corporate relationships as they unfold. Generex also will boost its social media presence through Twitter and Facebook.
Generex also hosts two additional websites: one for its wholly owned subsidiary, Antigen Express, as well as a site dedicated to providing reference information to patients and healthcare professionals that are interested in Generex’s proprietary buccal insulin spray product, Generex Oral-lyn, which can be accessed here.
Salix, Lupin ink technology deal for Xifaxan
RALEIGH, N.C. — Indian drug maker Lupin and U.S. drug maker Salix Pharmaceuticals announced Wednesday a licensing deal for technology related to a drug for traveler’s diarrhea.
Under the deal, Salix will receive exclusive worldwide rights for Xifaxan (rifaximin) drug technology developed by Lupin and jointly by both companies in all countries except India.
Salix is required to pay Lupin $10 million upfront, as well as potential payments related to regulatory milestones.
BioScrip receives URAC accreditation
ELMSFORD, N.Y. — Washington-based healthcare accrediting organization URAC has awarded specialty pharmacy and mail-service pharmacy accreditation to BioScrip, the specialty pharmacy provider said Wednesday.
“BioScrip is very pleased to have been awarded full accreditation for both specialty pharmacy and mail-serve pharmacy from URAC,” BioScrip president and CEO Richard Smith said. “Going through the process challenged us to find better ways to serve our customers, and it is a constant reminder that our first responsibility is to the patient and the quality of clinical serve we provide.”
The accreditation required BioScrip to participate in a complex application process that included comprehensive review of its customer service and clinical pharmacy processes against a combined 146 quality standards by expert analysts, the company said.